Loading publications…
The last 5 uploaded publications
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Roser Pinyol, Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín, Wei Qiang Leow, Catherine E. Willoughby, Pierluigi Ramadori, Carmen Andreu-Oller, Patricia Taik, Youngmin A. Lee, Agrin Moeini, Judit Peix, Suzanne Faure‐Dupuy, Tobias Riedl, Svenja Schuehle, Cláudia P. Oliveira, Venâncio Avancini Ferreira Alves, Paolo Boffetta, Anja Lachenmayer, Stephanie Roessler, Beatriz Mínguez, Peter Schirmacher, Jean‐François Dufour, Swan N. Thung, Helen L. Reeves, Flair José Carrilho, Charissa Chang, Andrew Uzilov, Mathias Heikenwälder, Arun J. Sanyal, Scott L. Friedman, Daniela Sia, Josep M. Llovet (2021). Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of Hepatology, 75(4), pp. 865-878, DOI: 10.1016/j.jhep.2021.04.049.
Article145 days agoImmunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber, Miho Maeda, Ugne Balaseviciute, Catherine E. Willoughby, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, Miguel Torres‐Martín, Judit Peix, Daniel Geh, Erik Ramón-Gil, Behnam Saberi, Scott L. Friedman, Derek A. Mann, Daniela Sia, Josep M. Llovet (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology, 74(5), pp. 2652-2669, DOI: 10.1002/hep.32023.
Article145 days agoCabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Roger Esteban-Fabró, Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix, Laura Torrens, Agavni Mesropian, Ugne Balaseviciute, Francesc Miró‐Mur, Vincenzo Mazzaferro, Roser Pinyol, Josep M. Llovet (2022). Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma. Clinical Cancer Research, 28(11), pp. 2449-2460, DOI: 10.1158/1078-0432.ccr-21-2517.
Article145 days agoTHU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Martí Torres-Marcen, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, David Camell, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ieva Keraite, Roger Esteban-Fabró, Takayuki Kimura, Alka A. Potdar, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Daniela Sia, Roser Pinyol, Josep M. Llovet (2025). THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma. Journal of Hepatology, 82, pp. S431-S432, DOI: 10.1016/s0168-8278(25)01237-1.
Article145 days agoSAT-113 The intratumoral microbiome in HCC and its impact on treatment response
Ugne Balaseviciute, Mohammad Rahbari, Fabian Springer, Roser Pinyol, Roger Esteban-Fabró, Albert Gris‐Oliver, Marta Piqué‐Gili, Agavni Mesropian, Jessica Zucman‐Rossi, Jeanin E. van Hooft, Josep M. Llovet, Mathias Heikenwälder (2025). SAT-113 The intratumoral microbiome in HCC and its impact on treatment response. Journal of Hepatology, 82, pp. S463-S463, DOI: 10.1016/s0168-8278(25)01307-8.
Article145 days ago